FDA Adverse Event Malfunction Summary report: N

TOSOH HLC-723G8 ANALYZER G8

MDR report key: 7364709 · Received March 22, 2018

Report

Report Number
8031673-2018-04207
Event Type
Malfunction
Date Received
March 22, 2018
Date of Event
March 16, 2017
Report Date
March 22, 2018
Manufacturer
TOSOH CORPORATION
Product Code
LCP
PMA / PMN Number
K071132
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

TOSOH BIOSCIENCE, INC. IS SUBMITTING ON BEHALF OF THE FOREIGN MANUFACTURER, TOSOH CORPORATION, PER EXEMPTION NUMBER E2017013. THIS REPORT IS BEING SUBMITTED DUE TO A RETROSPECTIVE REVIEW CONDUCTED UNDER CAPA-2017-0007. SUBMISSION OF THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE IMPORTER OR MANUFACTURER'S PRODUCT CAUSED OR CONTRIBUTED TO THE EVENT. ON 17-MAR-2017, FSE ARRIVED AT THE SITE TO ADDRESS THE REPORTED EVENT. FSE REPLACED THE SAMPLE LOOP, RAN WHOLE BLOOD, THEN QUALITY CONTROL (QC). NEXT, HE INSTRUCTED THE CUSTOMER TO RECALIBRATE AND RERUN CONTROLS. NO FURTHER ISSUES WERE REPORTED AND NO FURTHER ACTION WAS REQUIRED BY FIELD SERVICE. THE MOST PROBABLE CAUSE OF THE REPORTED EVENT WAS DUE TO FAULT/ FAILURE OF THE SAMPLE LOOP.

Description of Event or Problem · 0

ON (B)(6) 2017, THE CUSTOMER REPORTED HIGH PRESSURE WITH THEIR G8 ANALYZER. THEY CHANGED THE FILTER IN AN EFFORT TO TROUBLESHOOT BUT NOW THE DEVICE HAD NO PRESSURE. THE CUSTOMER, THEN ATTEMPTED A DRAIN FLUSH WITH NO RESOLUTION. AFTER INSPECTING THE DEVICE, HE FOUND THAT "THE SECOND VALVE DOWN WAS LEAKING". HE ATTEMPTED TO TIGHTEN THE TUBING BUT THE LEAK PERSISTED. ON (B)(4) 2017 FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED TO ADDRESS THE REPORTED EVENT, WHICH RESULTED IN DELAYED REPORTING HBA1C PATIENT RESULTS. THERE WAS NO INDICATION OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE DELAY IN REPORTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
206972 TOSOH HLC-723G8 ANALYZER G8 G8 LCP TOSOH CORPORATION G8

Patients

Seq Age Sex Outcome Treatment
1